Inovio Pharmaceuticals, Inc.

NASDAQ:INO

Biotechnology

Healthcare
$1.71 -0.90%

-$0.01 today

Market cap
$118.15M
Beta
1.49
P/E (TTM)
-8.9
EPS (TTM)
-$0.12
52W Low $1.03High $2.98

Volume 9.92M

Average 2.73M

Price history

Inovio Pharmaceuticals, Inc. SEC filings

Start with how the market priced the stock, then connect its moves to the disclosures filed with the SEC.

Price history

Dividend-adjusted closing price

Period change

-1.16%

Period high

$2.60

Period low

$0.74

Latest

$1.71

SEC filings

What has the company disclosed?

Browse annual, quarterly, and current reports and other filings by form type.

SEC Filings

Recent regulatory filings

FormFiling DateAccepted
424B5Nov 6, 2026Nov 6, 2026
FWPNov 6, 2026Nov 5, 2026
424B5Nov 5, 2026Nov 5, 2026
SC 13G/ANov 5, 2026Nov 5, 2026
8-KNov 5, 2026Nov 5, 2026
8-KNov 2, 2026Nov 2, 2026
8-KOct 6, 2026Oct 6, 2026
SC 13G/AAug 12, 2026Aug 12, 2026
10-QAug 12, 2026Aug 12, 2026
8-KAug 12, 2026Aug 12, 2026
SC 13GAug 7, 2026Aug 7, 2026
SC 13G/AAug 6, 2026Aug 6, 2026
8-KJul 31, 2026Jul 31, 2026
SC 13GJul 31, 2026Jul 31, 2026
424B5Jul 30, 2026Jul 30, 2026

Competitors

Who does Inovio Pharmaceuticals, Inc. compete with?

Open similar companies to compare their filings and price history.

Questions

Filing questions

Common questions about INO's filings, answered from its disclosures.

What is the latest INO filing?

The latest filing shown is 424B5 dated Nov 6, 2026.

How many recent filings does INO have?

Intrinsic Alpha currently shows 20 recent filings for INO.